Prescribers Discuss the Use of SGLT2 Inhibitors
Often, when a new class of drugs receives FDA approval, we hear from the investigators or medical professionals involved in the original studies and clinical trials and, although they may possess the most knowledge, they are often the least...
Viewpoints on Early Insulin Initiation
Diabetes In Control staff contacted several physicians all across the US to find out what they had to say about early insulin initiation. What they said may surprise you....
Dr. Stanley Schwartz on Early Insulin Use
Stanley Schwartz, MD, FACP, FACE, shares his views on early insulin...
Interview with Dr. Alan Moses, Global CMO, Novo Nordisk
In a special bonus issue of our GLP-1 Special Series, we presented this excellent and informative interview...
Interview with Dr. David D'Alessio, Internal Medicine-Endocrinology, Professor
Diabetes In Control Publisher Steve Freed interviewed Dr. David D'Alessio, Associate Professor of Medicine, Division of Endocrinology, University of Cincinnati, and the Albert Vontz chair in Diabetes Research. Dr. D'Alessio helps us...
Interview with David D'Alessio, MD; Internal Medicine-Endocrinology, Professor
What are the effects of using a GLP-1 drug when on the Atkins diet and a low-fat...
An Eye-Opening Interview with Steven Edelman, MD, PART 2
This week, we present the second half of our publisher Steve Freed's interview with Dr. Steven Edelman...
An Eye-Opening Interview with Steven Edelman, MD, Founder and Director, TCOYD
Our publisher, Steve Freed, sat down with Dr. Steven Edelman at the ADA Scientific Sessions in San...
Editor's Interview with Dr. Vivian A. Fonseca
Last month I had a chance to chat with Vivian A. Fonseca, MD, FRCP, Tulane University Medical Center, about the GLP-1 analogs....
Perspectives from Diabetes Thought Leaders on the Use of GLP-1 Agonists
Leading experts, Anne L. Peters, MD, Ralph A. DeFronzo, MD, Alan J. Garber, MD, PhD, Robert R. Henry, MD, Richard Bergenstal, MD, and others, share their thoughts on GLP-1 therapy....
An Endocrinologist's Perspective: Dr. Falal Taris, MD, Diabetes, Metabolism & Endocrinology, Internal Medicine
I have been using GLP-1 analogs with my patients for the past five years and have seen many patients find reasons to stop using the medication. They complain about nausea, they complain about the cost, they say the needle hurts and they have even...
